Federal Register / Vol. 62, No. 21 / Friday, January 31, 1997 / Notices 4781

Study section/contact person March 1997 meetings Time Location

Neurological Sciences Initial Review Group

Neurology A, Dr. Joe Marwah, 301–435–-1253 ....................... Mar. 4–6 ..................... 8:30 a.m. .................... Best Western Hotel, La Jolla,

CA.

The meetings will be closed in

accordance with the provisions set forth

in sections 552b(c)(4) and 552b(c)(6),

Title 5, U.S.C. Applications and/or

proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: January 23, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–2479 Filed 1–30–97; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Multidisciplinary Sciences.

Date: February 18, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 5116,

Telephone Conference.

Contact Person: Dr. Lee Rosen, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5116, Bethesda, Maryland 20892, (301)

435–1171.

Name of SEP: Chemistry and Related

Sciences.

Date: March 4, 1997.

Time: 3:00 p.m.

Place: Sheraton Hotel, Washington, DC.

Contact Person: Dr. Richard Panniers,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5106, Bethesda,

Maryland 20892, (301) 435–1166.

Name of SEP: Biological and Physiological

Sciences.

Date: March 12–14, 1997.

Time: 8:30 a.m.

Place: Doubletree Hotel, Rockville, MD.

Contact Person: Dr. Dennis Leszczyski,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6170, Bethesda,

Maryland 20892, (301) 435–1044.

Name of SEP: Biological and Physiological

Sciences.

Date: March 19, 1997.

Time: 9:00 a.m.

Place: Hyatt Regency, Bethesda, MD.

Contact Person: Dr. Richard Marcus,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5194, Bethesda,

Maryland 20892, (301) 435–1256.

Name of SEP: Biological and Physiological

Sciences.

Date: March 27–28, 1997.

Time: 8:30 a.m.

Place: American Inn, Bethesda, MD.

Contact Person: Dr. Nicholas Mazarella,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5128, Bethesda,

Maryland 20892, (301) 435–1018.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable materials and personal

information concerning individuals

associated with the applications and/or

proposals, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: January 23, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–2481 Filed 1–30–97; 8:45 am]

BILLING CODE 4140–01–M

National Center for Research

Resources

AGENCY: National Center for Research

Resources, NIH.

ACTION: Notice.

SUMMARY: The National Center for

Research Resources (NCRR), National

Institutes of Health (NIH), is updating

its 1994 strategic plan entitled NCRR: A

Catalyst for Discovery. Its purpose is to

anticipate, meet, and set priorities for

the biomedical research community’s

needs for critical research resources and

technologies. NCRR requests input from

biomedical scientists to identify barriers

to future research progress and to define

future needs for shared research

resources and technologies that

facilitate NIH-supported biomedical

research. NCRR’s existing 1994 strategic

plan may be assessed over the World

Wild Web: <http://www.ncrr.nih.gov/

plan94.htm>.

DATES: Submit responses to the Office of

Science Policy, NCRR (see below) on or

before May 15, 1997.

FOR FURTHER INFORMATION CONTACT: The

Office of Science Policy, NCRR/NIH,

One Rockledge Center, 6705 Rockledge

Drive MSC 7965, Suite 5046, Bethesda,

MD 20892–7965; 301–435–0866; FAX

301–480–3654; e-mail.

NCRRPLAN@EP.NCRR.NIH.GOV;

internet <http://www.ncrr.nih.gov>.

SUPPLEMENTARY INFORMATION: The

National Center for Research Resources

(NCRR) serves as a ‘‘catalyst for

discovery’’ by creating and providing

critical research technologies and

shared resources. This infrastructure

underpins biomedical research and

enables advances that improve the

health of our Nation’s citizens.

The NCRR serves a unique purpose at

the NIH: to develop critical research

technologies and to provide costeffective, shared, multidisciplinary

resources to biomedical investigators

across the spectrum of research

activities supported by the NIH. NCRR’s

mission to:

(1) Create resources and develop

technologies and research models that

are cost-effective, accessible, and

responsive to the research needs of the

biomedical research community. To

meet these needs, the NCRR must

anticipate evolving trends in basic and

clinical research to ensure that

resources will be available to facilitate

that research.

(2) Provide shared clinical, primate,

and biomedical technology resources

and instrumentation for use by

investigators supported by the NIH.

These resources, primarily centers,

serve more than 10,000 researchers, who

are supported through more than $1

billion of competitive awards from

NIH’s categorical Institutes.

(3) Develop quick, flexible approaches

to new and emerging biomedical

research needs and opportunities. These

innovations often involve high-risk

research.

(4) Strengthen the Nation’s

biomedical research infrastructure.

Support programs that develop and

enhance the capacity of institutions,

including underrepresented groups, to